Teva settles further price-fixing lawsuits in the US
Teva Pharmaceutical Industries (TSX: TEVA, NYSE: TEVA) has settled another lawsuit alleging price-fixing in the United States. Teva will pay $450 million in court-approved settlements in the United States, one for $425…
